Literature DB >> 15037813

Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2.

Naoyuki Kawao1, Hisao Ikeda, Tomoko Kitano, Ryotaro Kuroda, Fumiko Sekiguchi, Kazuo Kataoka, Yoshihisa Kamanaka, Atsufumi Kawabata.   

Abstract

Protease-activated receptors (PARs) 1 and 2 are expressed in capsaicin-sensitive sensory neurons, being anti- and pro-nociceptive, respectively. Given the possible cross talk between PAR-2 and capsaicin receptors, we investigated if PAR-2 activation could facilitate capsaicin-evoked visceral pain and referred hyperalgesia in the mouse and also examined the effect of PAR-1 activation in this model. Intracolonic (i.col.) administration of capsaicin triggered visceral pain-related nociceptive behavior, followed by referred hyperalgesia. The capsaicin-evoked visceral nociception was suppressed by intraperitoneal (i.p.) TFLLR-NH2, a PAR-1-activating peptide, but not FTLLR-NH2, a control peptide, and unaffected by i.col. TFLLR-NH2. SLIGRL-NH2, a PAR-2-activating peptide, but not LRGILS-NH2, a control peptide, administered i.col., facilitated the capsaicin-evoked visceral nociception 6-18 h after administration, while i.p. SLIGRL-NH2 had no effect. The capsaicin-evoked referred hyperalgesia was augmented by i.col. SLIGRL-NH2, but not LRGILS-NH2, 6-18 h after administration, and unaffected by i.p. SLIGRL-NH2, and i.p. or i.col. TFLLR-NH2. Our data suggest that PAR-1 is antinociceptive in processing of visceral pain, whereas PAR-2 expressed in the colonic luminal surface, upon activation, produces delayed sensitization of capsaicin receptors, resulting in facilitation of visceral pain and referred hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037813     DOI: 10.1254/jphs.94.277

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  13 in total

1.  Lesioning of TRPV1 expressing primary afferent neurons prevents PAR-2 induced motility, but not mechanical hypersensitivity in the rat colon.

Authors:  S K Suckow; E M Anderson; R M Caudle
Journal:  Neurogastroenterol Motil       Date:  2011-12-13       Impact factor: 3.598

Review 2.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

4.  2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.

Authors:  Atsufumi Kawabata; Yuko Oono; Daiki Yonezawa; Kaori Hiramatsu; Naoki Inoi; Fumiko Sekiguchi; Masami Honjo; Michiko Hirofuchi; Toru Kanke; Hiroyuki Ishiwata
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

5.  Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.

Authors:  Richard Róka; Afifa Ait-Belgnaoui; Christel Salvador-Cartier; Raphael Garcia-Villar; Jean Fioramonti; Hélène Eutamène; Lionel Bueno
Journal:  Gut       Date:  2007-02-19       Impact factor: 23.059

6.  Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice.

Authors:  Lena R Thurner; Klaus Höcherl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-27       Impact factor: 3.000

Review 7.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

8.  Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.

Authors:  Lijun Du; Yanqin Long; John J Kim; Binrui Chen; Yubin Zhu; Ning Dai
Journal:  Dig Dis Sci       Date:  2018-11-16       Impact factor: 3.199

9.  Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients.

Authors:  Zhao Xiang Bian; Zhi Li; Zhi Xin Huang; Man Zhang; Hong Li Chen; Hong Xi Xu; Joseph J Y Sung
Journal:  J Gastroenterol       Date:  2009-05-09       Impact factor: 7.527

10.  Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice.

Authors:  Atsufumi Kawabata; Maho Matsunami; Masahiro Tsutsumi; Tsuyoshi Ishiki; Osamu Fukushima; Fumiko Sekiguchi; Naoyuki Kawao; Takeshi Minami; Toru Kanke; Naohiro Saito
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.